Capital Research Global Investors

Capital Research Global Investors posted one of the most decisively bullish filings among the largest 13F managers: AUM surged ~$103B to $644.6 billion in Q1 2026, with 41 positions increased against just 2 decreased across a concentrated 459-name book. Its whale score of 77.25 is the highest in this cohort. The portfolio is anchored in AI semiconductors — Broadcom (5.57%), Microsoft (5.52%) and Nvidia (5.22%) together exceed 16% of assets — alongside Amazon (3.83%) and Eli Lilly (3.51%). The firm added heavily to Broadcom (~$6.0B) and Meta (~$5.9B) and opened large new stakes in Cisco (~$5.0B), UnitedHealth (~$4.6B) and Mondelez.